Bayer Acarbose 50mg Tablet Product Leaflet

The Bayer Acarbose 50mg tablet leaflet provides dosage, indications, side effects, contraindications, storage and other essential information.


Bayer Acarbose 50mg Tablet Product Leaflet - cover page
Brand
Bayer
Document type
Product Leaflet
Language
Chinese
Pages
4
File format
PDF
File size
330 KB
Published
30 September, 2026
Updated
30 September, 2026
MD5 checksum
3A55285D29AD091C81DB95AC56CB8E51

About this manual

This leaflet describes Bayer's Acarbose 50 mg tablets, a medication used together with diet control to treat type‑2 diabetes and reduce post‑prandial blood glucose. It lists the active ingredient, strength, form, and regulatory details.

Key sections cover dosage and administration, common adverse reactions, contraindications, precautions for pregnancy, lactation, children and the elderly, drug interactions, overdose handling, pharmacology, storage, packaging, shelf life and manufacturer information. This manual is written in Chinese.

What's inside

  • Product Name
  • Composition
  • Characteristics
  • Indications
  • Specification
  • Dosage and Administration
  • Adverse Reactions
  • Contraindications
  • Precautions
  • Pregnancy and Lactation

Specifications

Active ingredientAcarbose
Strength50 mg per tablet
FormTablet (white or pale yellow)
Molecular formulaC25H43NO18
Molecular weight645.63

Frequently asked questions

What is the recommended starting dosage?

The usual starting dose is one 50 mg tablet taken three times daily; the dose may be increased to 100 mg (two tablets) three times daily.

Can pregnant women use this medication?

Pregnant women should not use Acarbose tablets.

What are the main contraindications?

The drug is contraindicated in patients allergic to acarbose or its inactive ingredients, those with severe gastrointestinal disorders, and patients with severe renal impairment.

Download PDF (330 KB)

More Bayer Manuals


View all Bayer manuals →